现在可普遍获得对新冠肺炎的治疗。如果你新冠肺炎检测为阳性,请尽快与医生谈谈 治疗可选方案。
Test-to-Treat 检测到治疗项目是获得治疗的一种简便方式。Test-to-Treat 检测到治疗项目地点会为你提供检测和治疗。
搜索离你近的 Test-to-Treat 检测到治疗项目地点
完整接种疫苗并注射加强针,是防止因新冠肺炎患严重疾病和住院的最佳方式。
在 vaccines.gov (英语网站) 搜索疫苗或加强针
COVID 检测试剂盒可以在您出现症状、暴露于病毒或与他人见面之前帮助您确定自己是否感染 COVID-19。
请访问 COVIDtests.gov 订购免费检测试剂盒
Every U.S. household may place an order to receive four free COVID-19 rapid tests delivered directly to your home.
Need help placing an order for your at-home tests?
Call 1-800-232-0233 (TTY 1-888-720-7489).
The U.S. government will continue to make COVID-19 tests available to uninsured individuals and underserved communities through existing outreach programs. Please contact a HRSA health center, Test to Treat site, or ICATT location near you to learn how to access low- or no-cost COVID-19 tests provided by the federal government.
美国每个家庭都可以订购,即可获得 4 个免费的 COVID-19 快速检测试剂盒,直接送货到家。[按钮
需要帮助订购居家检测试剂盒?
请致电 1-800-232-0233 (TTY 1-888-720-7489)。
美国政府将继续通过现有的外展计划,为未参保个人和服务不足社区提供 COVID-19 检测服务。如需了解如何享受联邦政府提供的经济实惠或完全免费的 COVID-19 检测服务,请联系 健康中心、 从检测到治疗 (Test to Treat) 站点或您附近的 ICATT 地点。
COVID-19 and End of Public Health Emergency Update
The federal government confirmed May 11, 2023, as the end of the Public Health Emergency. Beginning May 12, 2023,
coverage for COVID-19 vaccines, testing and treatment will be as follows:
• COVID-19 vaccines — WellAway will cover COVID-19 vaccines and booster serum recommended by the Advisory
Committee on Immunization Practices as adopted by the Centers for Disease Control and Prevention, including the
administration of such vaccines and serums as part of your Wellness and Preventive Services benefit (if applicable)
and as stated in your Summary of Benefits.
• Over-the-Counter tests — WellAway will no longer cover over the counter COVID-19 tests for dates of service
starting after May 11, 2023, unless mandated by state regulatory requirements.
• Surveillance testing — WellAway will not cover surveillance testing.
• COVID-19 lab-based testing — WellAway will cover FDA approved or authorized COVID-19 lab tests ordered by
your physician or healthcare provider (e.g., pharmacist, nurse or doctor) as long as the test is: (i) consistent with the
CDC guidelines; (ii) diagnostic; and (iii) determined to be medically appropriate by an individual’s healthcare
provider in accordance with current accepted standards of medical practice. COVID-19 lab-based testing will only
be covered at an In-Network, independent free-standing facility (e.g., Quest Diagnostics, LabCorp) and is subject to
Deductible, Coinsurance, Copayment and Maximum Benefit amounts (as applicable) as stated in your policy terms
and conditions.
• COVID-19 treatment — WellAway will cover FDA approved or authorized COVID-19 treatments, including Paxlovid
and molnupiravir (Lagevrio), in accordance with your policy terms and conditions.
• Telehealth — WellAway will cover telehealth visits in accordance with your policy terms and conditions.
• Virtual Visits — WellAway will cover virtual visits in accordance with your policy terms and conditions.
We are available to answer any questions:
ConciergeCare U.S. +1-855-773-7810 | ConciergeCare International: +1-786-453-4008 (collect)
Email: conciergecare@wellaway.com
This material is for informational purposes only and is subject to change. Please refer to your Policy Terms and Conditions
for a complete description of the benefits, conditions, limitations and exclusions of coverage. Products and services may
not be available in all jurisdictions and are expressly excluded where prohibited by applicable law.
This material is for informational purposes only and is subject to change. Please refer to your Policy Terms and Conditions for a complete description of the benefits, conditions, limitations and exclusions of coverage. Products and services may not be available in all jurisdictions and are expressly excluded where prohibited by applicable law.